Upper Extremity Function in Multiple Sclerosis Patients With Advanced Disability Treated With Ocrevus
Conditions:  Multiple Sclerosis;  Pathologic Processes;  Demyelinating Diseases;  Demyelinating Autoimmune Diseases;  Nervous System Diseases;  Autoimmune Diseases;  Immune System Diseases;  Primary Progressive Multiple Sclerosis;  Relapsing Remitting Multiple Sclerosis Intervention:  Drug: Ocrelizumab Sponsors:  University of South Florida;  Genentech, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials